UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Anchorage-independent cell growth signature identifies tumors with metastatic potential

Oncogene, 2009-08, Vol.28 (31), p.2796-2805

2009

Volltextzugriff (PDF)

HER2/Neu tumorigenesis and metastasis is regulated by E2F activator transcription factors

Oncogene, 2015-01, Vol.34 (2), p.217-225

Andrechek, E R

2015

Volltextzugriff (PDF)

Effective personalized therapy for breast cancer based on predictions of cell signaling pathway activation from gene expression analysis

Oncogene, 2017-06, Vol.36 (25), p.3553-3561

2017

Volltextzugriff (PDF)

The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment

Oncogene, 2016-11, Vol.35 (47), p.6053-6064

2016

Volltextzugriff (PDF)

A mouse model with T58A mutations in Myc reduces the dependence on KRas mutations and has similarities to claudin-low human breast cancer

Oncogene, 2013-03, Vol.32 (10), p.1296-1304

2013

Volltextzugriff (PDF)

Heterogeneity in MYC-induced mammary tumors contributes to escape from oncogene dependence

Oncogene, 2012-05, Vol.31 (20), p.2545-2554

2012

Volltextzugriff (PDF)

Tyrosine kinase signalling in breast cancer: tyrosine kinase-mediated signal transduction in transgenic mouse models of human breast cancer

Breast cancer research : BCR, 2000-01, Vol.2 (3), p.211-216, Article 211

2000

Volltextzugriff (PDF)

Amplification of the neu/erbB-2 Oncogene in a Mouse Model of Mammary Tumorigenesis

Proceedings of the National Academy of Sciences - PNAS, 2000-03, Vol.97 (7), p.3444-3449

2000

Volltextzugriff (PDF)

Targeted disruption of ErbB2 Neu in the mammary epithelium results in impaired ductal outgrowth

Oncogene, 2005-01, Vol.24 (5), p.932-937

2005

Volltextzugriff (PDF)

ErbB2 Is Required for Muscle Spindle and Myoblast Cell Survival

Molecular and Cellular Biology, 2002-07, Vol.22 (13), p.4714-4722

2002

Volltextzugriff (PDF)

Gene expression profiling of neu-induced mammary tumors from transgenic mice reveals genetic and morphological similarities to erbb2-expressing human breast cancers

Cancer research (Chicago, Ill.), 2003-08, Vol.63 (16), p.4920-4926

2003

Volltextzugriff (PDF)

Germ-Line Expression of an Oncogenic erbB2 Allele Confers Resistance to erbB2-Induced Mammary Tumorigenesis

Proceedings of the National Academy of Sciences - PNAS, 2004-04, Vol.101 (14), p.4984-4989

2004

Volltextzugriff (PDF)

Abstract P1-03-04: Genomic Prediction and Genetic Validation of a Role for the E2F Transcription Factors in Breast Cancer

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (24_Supplement), p.P1-P1-03-04

Andrechek, ER

2010

Volltextzugriff (PDF)

The ErbB2[DELTA]Ex16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment

Oncogene, 2016-11, Vol.35 (47), p.6053

2016

Volltextzugriff (PDF)

Accelerated Mammary Tumor Development in Mutant Polyomavirus Middle T Transgenic Mice Expressing Elevated Levels of Either the Shc or Grb2 Adapter Protein

Molecular and Cellular Biology, 1999-12, Vol.19 (12), p.8169-8179

1999

Volltextzugriff (PDF)

Centrosome abnormalities, recurring deletions of chromosome 4, and genomic amplification of HER2/neu define mouse mammary gland adenocarcinomas induced by mutant HER2/neu

Oncogene, 2002-01, Vol.21 (6), p.890-898

2002

Volltextzugriff (PDF)

Centrosome abnormalities, recurring deletions of chromosome 4, and genomic amplification of HER2/neu define mouse mammary gland adenocarcinomas induced by mutant HER2/neu

Oncogene, 2002-01, Vol.21 (6), p.890-898

2002

Volltextzugriff (PDF)

Developmental timing of activated erbB2 expression plays a critical role in the induction of mammary tumors

Cell cycle (Georgetown, Tex.), 2004-09, Vol.3 (9), p.1111-1113

2004

Volltextzugriff (PDF)

Identification of an Unfavorable Immune Signature in Advanced Lung Tumors from Nrf2-Deficient Mice

Antioxidants & redox signaling, 2018-12, Vol.29 (16), p.1535-1552

2018

Volltextzugriff (PDF)

Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras

Nature biotechnology, 2006-08, Vol.24 (8), p.1005-1015

2006

Volltextzugriff (PDF)

Patterns of cell signaling pathway activation that characterize mammary development

Development (Cambridge), 2008-07, Vol.135 (14), p.2403-2413

2008

Volltextzugriff (PDF)

A role for E2F activities in determining the fate of Myc-induced lymphomagenesis

PLoS genetics, 2009-09, Vol.5 (9), p.e1000640-e1000640

2009

Volltextzugriff (PDF)

Distinct roles of E2F proteins in vascular smooth muscle cell proliferation and intimal hyperplasia

Proceedings of the National Academy of Sciences - PNAS, 2007-08, Vol.104 (32), p.12988-12993

2007

Volltextzugriff (PDF)

Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression

Cell death & disease, 2014-05, Vol.5 (5), p.e1242-e1242

2014

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

Animals
(22)
Science & Technology
(22)
Mice
(21)
Life Sciences & Biomedicine
(18)
Female
(14)
Humans
(14)
Tumors
(13)
Cell Biology
(12)
Biochemistry & Molecular Biology
(11)
Breast Cancer
(11)
Gene Expression
(11)
Mice, Transgenic
(11)
Oncology
(11)
Apoptosis
(9)
Genetics & Heredity
(9)
Breast Neoplasms - Genetics
(8)
Mammary Neoplasms, Experimental - Genetics
(8)
Breast Neoplasms - Pathology
(7)
Disease Models, Animal
(7)
Gene Expression Profiling
(7)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

8 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Anchorage-independent cell growth signature identifies tumors with metastatic potential

HER2/Neu tumorigenesis and metastasis is regulated by E2F activator transcription factors

Effective personalized therapy for breast cancer based on predictions of cell signaling pathway activation from gene expression analysis

The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment

A mouse model with T58A mutations in Myc reduces the dependence on KRas mutations and has similarities to claudin-low human breast cancer

Heterogeneity in MYC-induced mammary tumors contributes to escape from oncogene dependence

Tyrosine kinase signalling in breast cancer: tyrosine kinase-mediated signal transduction in transgenic mouse models of human breast cancer

Amplification of the neu/erbB-2 Oncogene in a Mouse Model of Mammary Tumorigenesis

Targeted disruption of ErbB2 Neu in the mammary epithelium results in impaired ductal outgrowth

ErbB2 Is Required for Muscle Spindle and Myoblast Cell Survival

Gene expression profiling of neu-induced mammary tumors from transgenic mice reveals genetic and morphological similarities to erbb2-expressing human breast cancers

Germ-Line Expression of an Oncogenic erbB2 Allele Confers Resistance to erbB2-Induced Mammary Tumorigenesis

An ErbB2/c-Src axis links bioenergetics with PRC2 translation to drive epigenetic reprogramming and mammary tumorigenesis

Abstract P1-03-04: Genomic Prediction and Genetic Validation of a Role for the E2F Transcription Factors in Breast Cancer

The ErbB2[DELTA]Ex16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment

Accelerated Mammary Tumor Development in Mutant Polyomavirus Middle T Transgenic Mice Expressing Elevated Levels of Either the Shc or Grb2 Adapter Protein

Centrosome abnormalities, recurring deletions of chromosome 4, and genomic amplification of HER2/neu define mouse mammary gland adenocarcinomas induced by mutant HER2/neu

Centrosome abnormalities, recurring deletions of chromosome 4, and genomic amplification of HER2/neu define mouse mammary gland adenocarcinomas induced by mutant HER2/neu

Developmental timing of activated erbB2 expression plays a critical role in the induction of mammary tumors

Identification of an Unfavorable Immune Signature in Advanced Lung Tumors from Nrf2-Deficient Mice

Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras

Patterns of cell signaling pathway activation that characterize mammary development

A role for E2F activities in determining the fate of Myc-induced lymphomagenesis

Distinct roles of E2F proteins in vascular smooth muscle cell proliferation and intimal hyperplasia

Tip30 controls differentiation of murine mammary luminal progenitor to estrogen receptor-positive luminal cell through regulating FoxA1 expression

Suchergebnisse filtern